About this meeting

The MHRA Board will meet in public on Tuesday 19 November 2024 from 10:00 until 12:30hrs. (GMT) by webinar.

The draft agenda for November will look at:

INTRODUCTION

1. What is the purpose of this meeting, who are the Board Directors and are there any absences?

2. Are there any new Declarations of Interest?

3. What were the minutes and actions from the last meeting?

AGENCY PERFORMANCE

4. What are the most important current activities and priorities from the CEO’s point of view?

5. What was the financial and people performance of the MHRA at the end of Q2 of 2024/25?

6. What was the Agency’s Operational Performance in Q2 of 2024/25?

INNOVATION

7. How is the strategy for licensing medicines progressing?

PATIENT SAFETY

8. What has been achieved in 60 years the Yellow Card Scheme, and how are we paving the way for the future?

9. What are we learning so far from the Yellow Card Biobank pilot studies, including the patient perspective?

ASSURANCE

10. ODRC Assurance Report

EXTERNAL PERSPECTIVE

11. What questions do members of the public have about the items on this Board Meeting Agenda?

We welcome members of the public at this meeting. Observers from the public can submit questions in advance on the items on the agenda at the November meeting. Questions on these topic areas will be prioritised and addressed at the question and answer session during the meeting. This is a Board Meeting held in public and not a public meeting and it will be at the Chair’s discretion to accept ad hoc questions on the day if there is available time.

Please note the deadline for pre-submitted questions is 09.00am (GMT) on Monday 11 November 2024. We will not accept any pre-submitted questions after this deadline.

Frequently Asked Questions

How do I pre-submit questions to the Board?

You can submit questions on the items for discussion at the meeting to the MHRA Board through the Eventbrite registration form, or alternatively email them to conferences@mhra.gov.uk by 09.00 am (GMT) on Monday 11 November 2024. We will not accept any pre-submitted questions after this deadline.

You may be selected to ask your pre-submitted question on camera during the question and answer session. If your question is selected, we will contact you directly to establish your consent.

When will I receive details of how to join the meeting?

Once your registration is confirmed, further joining instructions will be sent 48 hours before the meeting. These will include details of how to access the webinar, and how to submit questions, as well as links to the papers that will be discussed in the meeting.

How do I cancel my attendance if my plans change?

Email conferences@mhra.gov.uk with the email you used to register attendance and we will cancel your booking.

Access requirements:

We want you to be able to access and participate in the meeting. If you have any access requirements, please let us know when registering.

Meeting recording:

We will be recording this meeting using the Zoom recording function and plan to make this recording available for public viewing for up to three years.

You may be selected to ask your pre-submitted question on camera during the question and answer session. For information about how we collect and use personal information please see MHRA’s privacy notice.

You are reminded that consent is only sought for the MHRA to record the meeting for the purpose of publishing on GOV.UK. No consent is provided for anyone to take screenshots or photographs of the meeting. Recordings of the meeting must not be downloaded, copied, or distributed to any other person or location.

Get in touch:

If you have any further questions, please do get in touch by emailing conferences@mhra.gov.uk.

Data protection:

The Medicines and Healthcare products Regulatory Agency will use the information you have provided via the third-party data processor Eventbrite, to facilitate the event and provide you with an acceptable level of service. Any access requirements will be processed internally and will not be shared in any identifiable way with third-party organisations. We will contact you using the information provided for the purpose of this event. To find out how we use and manage your personal data please visit the MHRA’s privacy notice.

MHRA Board Meeting held in public